Marine Compounds Screening for Mortalin-p53 binding Inhibitor with Potential as Anti-Cancer

Main Authors: Wargasetia, Teresa L., Widodo, Nashi
Format: Proceeding PeerReviewed Book
Terbitan: , 2017
Subjects:
Online Access: http://repository.maranatha.edu/24982/1/Update_ECMNP%202017%20%2B%20poster.pdf
http://repository.maranatha.edu/24982/
ctrlnum 24982
fullrecord <?xml version="1.0"?> <dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><title>Marine Compounds Screening for Mortalin-p53 binding Inhibitor with Potential as Anti-Cancer</title><creator>Wargasetia, Teresa L.</creator><creator>Widodo, Nashi</creator><subject>R Medicine (General)</subject><description>Cancer is the second leading cause of death worldwide. High toxicity and side-effects of some cancer chemotherapy drugs increase the demand for new anti-cancer drugs from natural products. In recent years, attention has been devoted to searching for anti-cancer agents from marine natural products. Mortalin/mtHsp70, a stress response protein, has been reported to contribute to the process of carcinogenesis by several ways including inhibition of the transcriptional activation of p53. In this study, we used computational molecular docking as a tool to find compounds that have potential as anti-cancer by inhibiting the binding between mortalin and p53. &#xD; Marine compounds data was taken from the nuBBE database. To know the anti-cancer potential of the compounds from the database, docking mortalin to the p53 binding domain of the compounds were performed using the Vinaautodock algorithm with pyrx software. The potential inhibition of the binding of mortalin with p53 by the active compounds were analyzed by affinity binding between mortalin and the p53 binding domain of active compound ligands, also by a similarity between the position of mortalin-active compound ligand bindings with mortalin-withanone binding as a positive control. Proteins were visualized with discorystudio software. &#xD; </description><date>2017-09-03</date><type>Journal:Proceeding</type><type>PeerReview:PeerReviewed</type><type>Book:Book</type><identifier>http://repository.maranatha.edu/24982/1/Update_ECMNP%202017%20%2B%20poster.pdf</identifier><identifier> Wargasetia, Teresa L. and Widodo, Nashi (2017) Marine Compounds Screening for Mortalin-p53 binding Inhibitor with Potential as Anti-Cancer. In: 10th European Conference on Marine Natural Products, September 3-7, 2017, Crete. </identifier><relation>http://repository.maranatha.edu/24982/</relation><recordID>24982</recordID></dc>
format Journal:Proceeding
Journal
PeerReview:PeerReviewed
PeerReview
Book:Book
Book
author Wargasetia, Teresa L.
Widodo, Nashi
title Marine Compounds Screening for Mortalin-p53 binding Inhibitor with Potential as Anti-Cancer
publishDate 2017
topic R Medicine (General)
url http://repository.maranatha.edu/24982/1/Update_ECMNP%202017%20%2B%20poster.pdf
http://repository.maranatha.edu/24982/
contents Cancer is the second leading cause of death worldwide. High toxicity and side-effects of some cancer chemotherapy drugs increase the demand for new anti-cancer drugs from natural products. In recent years, attention has been devoted to searching for anti-cancer agents from marine natural products. Mortalin/mtHsp70, a stress response protein, has been reported to contribute to the process of carcinogenesis by several ways including inhibition of the transcriptional activation of p53. In this study, we used computational molecular docking as a tool to find compounds that have potential as anti-cancer by inhibiting the binding between mortalin and p53. Marine compounds data was taken from the nuBBE database. To know the anti-cancer potential of the compounds from the database, docking mortalin to the p53 binding domain of the compounds were performed using the Vinaautodock algorithm with pyrx software. The potential inhibition of the binding of mortalin with p53 by the active compounds were analyzed by affinity binding between mortalin and the p53 binding domain of active compound ligands, also by a similarity between the position of mortalin-active compound ligand bindings with mortalin-withanone binding as a positive control. Proteins were visualized with discorystudio software.
id IOS3452.24982
institution Universitas Kristen Maranatha
institution_id 45
institution_type library:university
library
library Perpustakaan Universitas Kristen Maranatha
library_id 530
collection Maranatha Repository System
repository_id 3452
subject_area Ekonomi
Kesehatan dan Kedokteran
Program Komputer dan Teknologi Informasi
city BANDUNG
province JAWA BARAT
repoId IOS3452
first_indexed 2019-05-06T01:01:28Z
last_indexed 2019-05-06T01:01:28Z
recordtype dc
_version_ 1685954301248143360
score 17.60897